Transdermally applied iloprost (ZK36-374) decreases whole blood platelet aggregation in normal volunteers

Prog Clin Biol Res. 1987:242:413-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Dose-Response Relationship, Drug
  • Epoprostenol / administration & dosage*
  • Epoprostenol / pharmacology
  • Humans
  • Iloprost
  • Kinetics
  • Platelet Aggregation / drug effects*
  • Reference Values

Substances

  • Epoprostenol
  • Iloprost